Martin, M; Hurvitz, SA; Chan, D; Fernandez-Abad, M; Petru, E; Rostorfer, R; Guarneri, V; Huang, CS; Press, MF; Costigan, TM; Caldwell, CW; Wijayawardana, S; Turner, PK; Barriga, S; Slamon, DJ.
Final results of NeoMONARCH: A phase 2 neoadjuvant study of abemaciclib in postmenopausal women with hormone receptor positive (HR+), HER2 negative breast cancer (BC)
CANCER RES. . 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX.
[Poster]
Web of Science